Skip to content

Effects of mechanical vibration generated on a vibratory platform in patients with Chronic Obstructive Pulmonary Disease

Effects of mechanical vibration on oscillating/vibration platform in patients with Chronic obstructive pulmonary disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-72dqtm
Enrollment
Unknown
Registered
2019-08-14
Start date
2017-02-04
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Whole-body vibration exercises (WBVE), promoted by mechanical vibrations generated on a vibratory platform (VP). The brand of PV is Novaplate Fitness Evolution, DAF Produtos Hospitalares Ltda., From E
group sitting in chair 2x (S2G = 30) and group exposed to standing EVCI (SG = 30). In the sitting position, the subjects will be placed in a chair with their hands resting on their knees and their fee
Device
Other

Sponsors

Universidade do Estado do Rio de Janeiro
Lead Sponsor
Universidade do Estado do Rio de Janeiro
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients of both sexes, under follow-up at Serviço de Pneumologia do HUPE, diagnosed with COPD based on the criteria established by GOLD; patients with stable disease; with Forced Expiratory Volume in the 1st Second less than 50%; independent patients; signed by the Free and Informed Consent Form.

Exclusion criteria

Exclusion criteria: Patients with exacerbation for less than 3 months; patients with labyrinthitis; patients with osteoporosis reported; patients with other respiratory diseases; patients using pacemaker; patients with previous history of fractures or other orthopedic diseases submitted to surgeries with implantation of metallic material; patients with peripheral vascular disease or thromboembolism; patients smoker or severe alcoholic; patients with decompensated cardiovascular disease; patients with aneurysm; patients with previous vitreous hemorrhage; patients in malnutrition; postoperative patients; patients with neurological disease that causes "fear" of movements on the vibrating platform; severe or incapacitating clinical illness, at the discretion of the investigator.

Design outcomes

Primary

MeasureTime frame
To evaluate the effects of WBVE on the electromyographic tracing of the vastus lateralis, vastus medialis and rectus femoris, through surface electromyography in individuals with COPD;To evaluate the effects of WBVE on blood pressure, heart rate, respiratory rate and oxygen saturation through pulse oximetry in individuals with COPD;To evaluate the effects of WBVE on dyspnea, through the Modified Scale of BORG and Medical Research Council (MRC) in individuals with COPD

Secondary

MeasureTime frame
To evaluate the effects of WBVE on flexibility, through the anterior trunk flexion (ATF) test in individuals with COPD;To evaluate the effects of WBVE on palmar grip strength through dynamometry in individuals with COPD;To evaluate the effects of WBVE on gait, balance and functional/lower limb strength through the Short Physical Performance Battery (SPPB) in individuals with COPD;To evaluate the effects of WBVE on fatigue through the BORG Scale, and on the effort through the Subjective Effort Perception Scale in individuals with COPD;To evaluate the effects of WBVE on quality of life using the St. Georges Respiratory Questionnaire (SGRQ) in individuals with COPD;To evaluate the effects of WBVE on the impact of COPD symptoms through the COPD assessment test (CAT) in individuals with COPD;To evaluate the effects of WBVE on biochemical blood markers, by means of blood sample collection in individuals with COPD;To evaluate the effects of WBVE on body composition through bioimpedance analysis in individuals with COPD;To assess the effects of WBVE on the composition Evaluate the effects of VCT on maximal inspiratory pressure and maximal expiratory pressure through manovacuometry in individuals with COPD

Countries

Brazil

Contacts

Public ContactMario Bernardo Filho

Universidade do Estado do Rio de Janeiro

bernardofilhom@gmail.com+552128688332

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 9, 2026